Condition
Vasospastic Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01612273Phase 4CompletedPrimary
The Effect of Triflusal on Peripheral Microcirculation Dysfunction
NCT00675181Not ApplicableCompletedPrimary
Effects of Melatonin and Oxygen Consumption and Choroidal Blood Flow
NCT00409123CompletedPrimary
Effect of Systemic Cooling in Vasospasms
NCT00319371CompletedPrimary
Registration of Skin-Temperatures and Sleep-Wake Behaviour
Showing all 4 trials